Ameriprise Portfolio holdings
Ameriprise Financial, Inc., founded in 1894 as Investors Syndicate and headquartered in Minneapolis, Minnesota, is a leading financial services firm specializing in wealth management, financial planning, and insurance, managing hundreds of billions in assets for individual and institutional clients. Evolving from its roots in investment certificates, it now offers a comprehensive suite of services, including retirement planning, annuities, mutual funds, and advisory solutions, delivered through a network of over 10,000 financial advisors across the U.S. Known for its client-first approach, Ameriprise became independent in 2005 after spinning off from American Express, focusing on personalized advice and robust digital tools to compete in a crowded market. With a strong emphasis on long-term relationships and financial security, Ameriprise has grown into a trusted name in the retail investment and insurance sectors.
Top Buys
| 1 |
Alphabet (Google) Class A
GOOGL
|
$646M |
| 2 |
Gilead Sciences
GILD
|
$598M |
| 3 |
NVIDIA
NVDA
|
$538M |
| 4 |
Altria Group
MO
|
$367M |
| 5 |
Synopsys
SNPS
|
$300M |
Top Sells
| 1 |
AbbVie
ABBV
|
$580M |
| 2 |
eBay
EBAY
|
$488M |
| 3 |
Lam Research
LRCX
|
$368M |
| 4 |
Trane Technologies
TT
|
$280M |
| 5 |
Dropbox
DBX
|
$268M |
Sector Composition
| 1 | Technology | 25.11% |
| 2 | Financials | 11.83% |
| 3 | Industrials | 8.16% |
| 4 | Healthcare | 7.52% |
| 5 | Consumer Discretionary | 7.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
HPP
3776
Hudson Pacific Properties
HPP
$1.07B
| $123K | ﹤0.01% |
44,841
-1,190
| -3% | -$3.26K |
|
3777
Atea Pharmaceuticals
AVIR
$271M
| $122K | ﹤0.01% |
33,751
| – | – |
|
3778
Novavax
NVAX
$1.23B
| $120K | ﹤0.01% |
19,090
-12,656
| -40% | -$79.7K |
|
3779
Invesco Pennsylvania Value Municipal Income Trust
VPV
$179M
| $119K | ﹤0.01% |
11,822
| – | – |
|
|
CRF
3780
Cornerstone Total Return Fund
CRF
$1.21B
| $115K | ﹤0.01% |
14,854
| – | – |
|
3781
Sibanye-Stillwater
SBSW
$6.11B
| $115K | ﹤0.01% |
15,918
+2,874
| +22% | +$20.8K |
|
3782
Intellia Therapeutics
NTLA
$1.25B
| $111K | ﹤0.01% |
11,803
+1,443
| +14% | +$13.5K |
|
3783
Weibo
WB
$2.82B
| $109K | ﹤0.01% |
11,461
-3,402
| -23% | -$32.4K |
|
|
PMX
3784
DELISTED
PIMCO Municipal Income Fund III
PMX
| $109K | ﹤0.01% |
15,831
+3,004
| +23% | +$20.6K |
|
|
ELEV
3785
DELISTED
Elevation Oncology
ELEV
| $108K | ﹤0.01% |
294,326
-4,464
| -1% | -$1.64K |
|
3786
Zentalis Pharmaceuticals
ZNTL
$123M
| $106K | ﹤0.01% |
91,195
+78,578
| +623% | +$91.2K |
|
|
LAR
3787
Lithium Argentina AG
LAR
$547M
| $105K | ﹤0.01% |
50,443
-3,594
| -7% | -$7.48K |
|
3788
1-800-Flowers.com
FLWS
$352M
| $104K | ﹤0.01% |
21,214
-673,996
| -97% | -$3.32M |
|
3789
Sandstorm Gold
SAND
$3.32B
| $103K | ﹤0.01% |
10,995
-659
| -6% | -$6.2K |
|
3790
Smith & Wesson
SWBI
$361M
| $101K | ﹤0.01% |
+11,620
| New | +$101K |
|
3791
Aldeyra Therapeutics
ALDX
$352M
| $101K | ﹤0.01% |
+26,263
| New | +$101K |
|
3792
BlackRock Long-Term Municipal Advantage Trust
BTA
$121M
| $101K | ﹤0.01% |
+10,968
| New | +$101K |
|
|
ZH
3793
Zhihu
ZH
$430M
| $99.5K | ﹤0.01% |
+25,006
| New | +$99.5K |
|
|
MAV
3794
DELISTED
Pioneer Municipal High Income Advantage Fund
MAV
| $97.9K | ﹤0.01% |
11,791
-85
| -0.7% | -$705 |
|
3795
Wipro
WIT
$28.9B
| $97.4K | ﹤0.01% |
32,261
-9,457
| -23% | -$28.6K |
|
|
JMIA
3796
Jumia Technologies
JMIA
$970M
| $96.9K | ﹤0.01% |
24,109
+2,627
| +12% | +$10.6K |
|
3797
Grifois
GRFS
$6.61B
| $94.5K | ﹤0.01% |
+10,456
| New | +$94.5K |
|
|
PGRE
3798
Paramount Group
PGRE
$1.61B
| $85.5K | ﹤0.01% |
14,023
-25,100
| -64% | -$153K |
|
|
BCYC
3799
Bicycle Therapeutics
BCYC
$496M
| $85.5K | ﹤0.01% |
+12,304
| New | +$85.5K |
|
3800
Frontier Group Holdings
ULCC
$1.28B
| $85.3K | ﹤0.01% |
23,489
-5,496
| -19% | -$20K |
|